Global Drugmakers Commit Hundreds of Billions to Expand U.S. Manufacturing

Major pharmaceutical companies are significantly expanding their manufacturing and research presence in the United States, with companies including Pfizer, Eli Lilly, Johnson & Johnson, Roche, AstraZeneca and Novartis announcing investments that together approach $500 billion. The investments cover new manufacturing facilities, research and development centers, supply-chain infrastructure and expansions of existing sites. The moves come […]

Continue Reading

India’s Pharmaceutical Industry Faces Lower 2030 Sales Outlook Amid Trade and Shipping Disruptions

India’s pharmaceutical industry is expected to fall significantly short of its previously established sales target for 2030 as trade uncertainty and disruptions to international shipping weigh on the sector. The Pharmaceuticals Export Promotion Council of India now expects the country’s pharmaceutical industry to reach approximately $80 billion to $90 billion in sales by 2030. That […]

Continue Reading